Nelson Capital Management, LLC Bristol Myers Squibb CO Transaction History

Nelson Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$49.21 - $64.19 $149,007 - $194,367	-3,028 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$42.77 - $50.71 $30,366 - $36,004	710 Added 30.63%	3,028 $154,000
Q2 2019 Jul 25, 2019	SELL	$44.62 - $49.34 $1,338 - $1,480	-30 Reduced 1.28%	2,318 $105,000
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $3.8 Million - $4.53 Million	-84,237 Reduced 97.29%	2,348 $112,000
Q4 2018 Jan 30, 2019	SELL	$48.76 - $63.23 $211,618 - $274,418	-4,340 Reduced 4.77%	86,585 $4.5 Million
Q3 2018 Oct 09, 2018	BUY	$55.19 - $62.25 $92,719 - $104,580	1,680 Added 1.88%	90,925 $5.65 Million
Q2 2018 Jul 17, 2018	BUY	$50.53 - $62.98 $118,593 - $147,814	2,347 Added 2.7%	89,245 $4.94 Million
Q1 2018 Apr 20, 2018	SELL	$59.92 - $68.98 $21,571 - $24,832	-360 Reduced 0.41%	86,898 $5.5 Million
Q4 2017 Jan 26, 2018	SELL	$59.94 - $65.35 $4,015 - $4,378	-67 Reduced 0.08%	87,258 $5.35 Million
Q3 2017 Nov 02, 2017	BUY	$55.23 - $63.74 $32,309 - $37,287	585 Added 0.67%	87,325 $5.57 Million
Q2 2017 Aug 11, 2017	BUY	N/A	86,740	86,740 $4.83 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Nelson Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nelson Capital Management, LLC with notifications on news.